ExpreS2ion Biotech Holding AB (FRA:5JD0) Total Long-Term Liabilities : €0.16 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is ExpreS2ion Biotech Holding AB Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. ExpreS2ion Biotech Holding AB's Total Long-Term Liabilities for the quarter that ended in Dec. 2024 was €0.16 Mil.

ExpreS2ion Biotech Holding AB Total Long-Term Liabilities Historical Data

The historical data trend for ExpreS2ion Biotech Holding AB's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ExpreS2ion Biotech Holding AB Total Long-Term Liabilities Chart

ExpreS2ion Biotech Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Long-Term Liabilities

Get a 7-Day Free Trial

0.60

0.40

0.24

0.17

0.16

ExpreS2ion Biotech Holding AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Long-Term Liabilities	Get a 7-Day Free Trial															0.17	0.17	0.19	0.18	0.16

ExpreS2ion Biotech Holding AB Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

ExpreS2ion Biotech Holding AB Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of ExpreS2ion Biotech Holding AB's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

ExpreS2ion Biotech Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (FRA:5JD0) » Definitions » Total Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

EXPRS2:Sweden

Address

c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, 252 25

Website

https://www.expres2ionbio.com

ExpreS2ion Biotech Holding AB is a biotechnology company that develops vaccines. It has developed a human clinical Phase III-validated technology platform, ExpreS2, for fast and efficient development and production of the active material in vaccines. The platform, under the brand GlycoX-S2, includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. Its product pipeline comprises ES2B-C001, a HER2-VLP-based vaccine in development for human breast cancer therapy; ES2B-I002, a Cytomegalovirus (CMV) vaccine; and several exploratory vaccine projects targeting pathways validated by commercial monoclonal antibody products. Geographically, the company operates in the Nordics region and also has a presence in other countries.

ExpreS2ion Biotech Holding AB Headlines

No Headlines